Quantum Machines selects ORCA Computing for Quantum Computing Centre

ORCA Computing has been chosen to partner with Quantum Machines, an Israeli company, to establish the newly announced Israeli Quantum Computing Centre.

The facility has bought an ORCA PT-1 model, the first computer of its kind able to work at room temperature and on-site.

ORCA is the only UK quantum processor developer selected to partner with the new centre, which will develop a research and development base for industry and academia to develop applications and uses.

The sale was announced by the Israel Innovation Authority.

ORCA Computing CEO Richard Murray said: “We’re delighted to help establish quantum computing in Israel and look forward to developing applications and uses. This is a significant milestone for us as the second sale we’ve made to a government. It also involves a commitment beyond the initial computer to future upgraded models.”

Orit Farkash-Hacohen, Israeli Minister of Innovation, Science and Technology, described the new centre as “a substantial leap in the Israeli civilian technology’s fortitude.”

The centre has selected leading partners from around the globe to support three different quantum processing technologies: superconducting qubits, cold ions and photonic qubits.

ORCA software allows small scale photonic processors, which use single units of light, to be applied to complex machine learning and optimisation tasks.

The centre is being established by Quantum Machines, which specialises in control and operation systems for quantum computers. The other developers chosen to partner with the centre are US-based ColdQuanta and QuantWare, a developer based in the Netherlands.

The UK Ministry of Defence announced last month that it is also to work with a PT-1, acquiring the UK Government’s first quantum computer.

This announcement contains forward looking statements. Members of the consortium that have been awarded to develop the Israeli national quantum computing centre expect to project to commence following contract.